Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anthony Kim, Jennifer Nguyen, Mahsa Babaei, Ahlee Kim, David H Geller & Alaina P Vidmar. (2023) A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity. Adolescent Health, Medicine and Therapeutics 14, pages 125-140.
Read now
Read now
Cenk Tek. (2016) Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives. Patient Preference and Adherence 10, pages 751-759.
Read now
Read now
Articles from other publishers (3)
Lin Zhang, Zhi Liu, Shenling Liao, He He & Mei Zhang. (2021) Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 77:11, pages 1611-1621.
Crossref
Crossref
Shazia Jehan, Ferdinand Zizi, Seithikurippu R Pandi-Perumal, Samy I McFarlane, Girardin Jean-Louis & Alyson K Myers. (2020) Energy imbalance: obesity, associated comorbidities, prevention, management and public health implications. Advances in Obesity, Weight Management & Control 10:5, pages 146-161.
Crossref
Crossref
Hermann Toplak, Euan Woodward, Volkan Yumuk, Jean-Michel Oppert, Jason C.G. Halford & Gema Frühbeck. (2015) 2014 EASO Position Statement on the Use of Anti-Obesity Drugs. Obesity Facts 8:3, pages 166-174.
Crossref
Crossref